Thalassemia, Beta: Clinical Trials

4 trials for Thalassemia, Beta, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Recruiting 1, Unknown 1
Phase 32Completed 2

Follow Thalassemia, Beta: new trials by email Literature Review of Thalassemia, Beta trials Research Report on Thalassemia, Beta

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Fludarabine, Cyclophosphamide, Tacrolimus - Sickle Cell Disease, Thalassemia, Beta
Phase 2RecruitingMemorial Sloan Kettering Cancer Center242023-02-092026-06-03
Thalidomide and Hydroxyurea Combination in β-Thalassemia Patients
Hydroxyurea and Thalidomide - Thalassemia, Beta
Phase 2 / Phase 3CompletedChildren's Hospital Karachi6032020-07-072023-12-01
Clinical Experience of Thalidomide in Thalassemic Patients
hydroxyurea and thalidomide - Thalassemia, Beta
Phase 2 / Phase 3CompletedChildren's Hospital Karachi1352020-01-012021-11-24
The Efficacy and Safety of HYDROXYUREA in Management of Beta Thalassemia Patients in Karachi Pakistan
Hydroxyurea - Thalassemia, Beta
Phase 2UnknownDr.Saqib Hussain Ansari1002017-08-212017-09-20

Narrower conditions

beta-Thalassemia (4)  ·  Anemia, Sickle Cell (1)  ·  Thalassemia (1)

Broader conditions

Anemia (4)  ·  Anemia, Hemolytic (4)  ·  Anemia, Hemolytic, Congenital (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Hemoglobinopathies (4)  ·  Thalassemia (3)

Interventions

Hydroxyurea (3)  ·  Thalidomide (2)  ·  Bortezomib (1)  ·  Cyclophosphamide (1)  ·  Dexamethasone (1)  ·  Mycophenolic Acid (1)  ·  Rituximab (1)  ·  Tacrolimus (1)  ·  fludarabine (1)  ·  thymoglobulin (1)

Sponsors

Children's Hospital Karachi (2)  ·  Dr.Saqib Hussain Ansari (1)  ·  Memorial Sloan Kettering Cancer Center (1)

Countries

Pakistan (3)  ·  United States (1)

Top investigators

Maria Cancio, MD (1)  ·  Saqib H Ansari, MBBS, DCH, DPGN, Mphil, PhD (1)  ·  Saqib H Ansari, Phd (1)

Results publications

PMID 35477175